Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société ABBOTT LABORATORIES
2020ABBOTT : 's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes,..
PR
2020ABBOTT LABORATORIES : New Late-Breaking Data Show Use of Abbott's FreeStyle® Libre System ..
AQ
2020ABBOTT : Declares 386th Consecutive Quarterly Dividend
PR
2020VIROGATES A/S : announces CE-IVD approval and launch of suPARnostic® TurbiLatex on the Abb..
AQ
2020Credit of Final Cash Dividend of Abbott Laboratories Limited
AQ
2020Transmission of Quarterly Report for the Period Ended March 31, 2020 of Abbott Laborato..
AQ
2020Transmission of Quarterly Report for the Period Ended March 31, 2020 of Abbott Laborato..
AQ
2020Re-appointment of Chief Executive of Abbott Laboratories Limited
AQ
2020Re-appointment of Chairman of Abbott Laboratories Limited
AQ
2020Financial results of Abbott Laboratories Limited for Quarter ended March 31, 2020
AQ
2020Election of Directors of Abbott Laboratories Limited
AQ
2020Board of directors meeting of Abbott Laboratories Limited
AQ
2020Board Meeting in Progress of Abbott Laboratories Limited
AQ
2020ABBOTT : Releases Interim Clinical Study Data on ID NOW COVID-19 Rapid Test Showing Strong..
PR
2020ABBOTT : Announces Contract to Supply Millions of IgG Lab-Based Antibody Tests to the UK G..
PR
2020Board of directors meeting of Abbott Laboratories Limited
AQ
2020ABBOTT LABORATORIES : Announces Health Canada Authorization Under the COVID-19 Interim Ord..
AQ
2020Election of Directors of Abbott Laboratories Limited
AQ
2020GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Investigation..
BU
2020INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims Against Abb..
BU
2020THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation on Behalf of Abbott Laboratorie..
BU
2020Law Offices of Howard G. Smith Announces Investigation of Abbott Laboratories (ABT) on ..
BU
2020Election of Directors of Abbott Laboratories Limited
AQ
2020ABBOTT LABORATORIES : FDA probes accuracy issue with Abbott's rapid virus test
AQ
2020ABBOTT : Provides Update on ID NOW™
PR
2020ABBOTT LABORATORIES : Receives fda emergency use authorization for covid-19 molecular test..
AQ
2020Election of Directors of Abbott Laboratories Limited
AQ
2020ABBOTT : Receives FDA Emergency Use Authorization for COVID-19 Molecular Test on New Alini..
PR
2020ABBOTT LABORATORIES : FDA gives emergency authorization to antibody test from Abbott Labs
AQ
2020ABBOTT LABORATORIES : Research from university of washington demonstrates high performance..
AQ
2020ABBOTT LABORATORIES : New Lawsuit Alleges Fiduciary Breaches By Plan Sponsor And Recordkee..
AQ
2020ABBOTT LABORATORIES : Research from University of Washington Demonstrates High Performance..
PR
2020ABBOTT LABORATORIES : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
2020ABBOTT LABORATORIES : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2020ABBOTT LABORATORIES : Receives health canada authorization under interim order to use free..
AQ
2020ABBOTT LABORATORIES : Receives Health Canada Authorization under Interim Order to Use Free..
AQ
2020ABBOTT LABORATORIES : Thinking about trading options or stock in Abbott Laboratories, Docu..
PR
2020ABBOTT LABORATORIES : 1Q 2020 Earnings Infographic
PU
2020ABBOTT LABORATORIES : Results of Operations and Financial Condition, Financial Statements ..
AQ
2020ABBOTT : 1Q Earnings Snapshot
AQ
2020ABBOTT : Reports First-Quarter 2020 Results
PR
2020ABBOTT : Launches Third COVID-19 Test, a Laboratory-Based Antibody Blood Test That Will Sh..
PR
2020ABBOTT : Announces Virtual Attendance at Annual Meeting of Shareholders
PR
2020Grant of Extension for filing Financial Statement of Abbott Laboratories Limited
AQ
2020ABBOTT LABORATORIES : Triclip becomes first device of its kind to receive ce mark for mini..
AQ
2020ABBOTT : 's TriClip™ Becomes First Device of its Kind to Receive CE Mark for Minimal..
PR
2020Grant of Extension for filing Financial Statement of Abbott Laboratories Limited
AQ
2020Postponement of 71st Annual General Meeting of Abbott Laboratories Limited
AQ
2020ABBOTT LABORATORIES : Thinking about trading options or stock in Abbott Laboratories, Auto..
PR
2020Abbott, Johnson & Johnson rise; SeaWorld, Carnival Fall
AQ
2020ABBOTT LABORATORIES : Launches molecular point-of-care test to detect novel coronavirus in..
AQ
2020ABBOTT : Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as..
PR
2020Transmission of Annual Report for the Year Ended December 31, 2019 of Abbott Laboratori..
AQ
2020ABBOTT : Hosts Conference Call for First-Quarter Earnings
PR
2020ABBOTT : Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Corona..
PR
2020Annual general meeting of Abbott Laboratories Limited to be held on April 20, 2020
AQ
2020ABBOTT LABORATORIES : Aims to optimize tavi implants with european approval of flexnav del..
AQ
2020ABBOTT : Aims to Optimize TAVI Implants with European Approval of FlexNav™ Delivery ..
PR
2020Financial results of Abbott Laboratories Limited for Year ended December 31, 2019
AQ
2020ABBOTT LABORATORIES : Change in Directors or Principal Officers, Amendments to Articles of..
AQ
2020Board of directors meeting of Abbott Laboratories Limited
AQ
2020ABBOTT LABORATORIES : Declares 385th consecutive quarterly dividend
AQ
2020ABBOTT LABORATORIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2020ABBOTT : Declares 385th Consecutive Quarterly Dividend
PR
2020ABBOTT : Introduces Next-Generation Heart Rhythm Management Devices in Europe, Featuring S..
PR
2020ABBOTT LABORATORIES : Change in Directors or Principal Officers (form 8-K)
AQ
2020ABBOTT : 's In-Development Fully Implantable Heart Pump System Earns FDA's Breakthrough De..
PR
2020ABBOTT : Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk..
PR
2020ABBOTT LABORATORIES : Tendyne device receives world's first ce mark for transcatheter mitr..
AQ
2020ABBOTT : 's Tendyne™ Device Receives World's First CE Mark for Transcatheter Mitral ..
PR
2020ABBOTT LABORATORIES : Receives expanded indication from the u.s. fda for directional deep ..
AQ
2020ABBOTT : Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimula..
PR
2020ABBOTT LABORATORIES : New quality of life and functional improvement data from abbott's bo..
AQ
2020ABBOTT LABORATORIES : Results of Operations and Financial Condition, Financial Statements ..
AQ
2020ABBOTT : 4Q Earnings Snapshot
AQ
Prev.1  2   3  4  5  6  7  8  9  10Next
Upcoming event on ABBOTT LABORATORIES
10/14/21